These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38494955)

  • 1. Antibody-epitope conjugates deliver immunogenic T-cell epitopes more efficiently when close to cell surfaces.
    van der Wulp W; Luu W; Ressing ME; Schuurman J; van Kasteren SI; Guelen L; Hoeben RC; Bleijlevens B; Heemskerk MHM
    MAbs; 2024; 16(1):2329321. PubMed ID: 38494955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-mediated delivery of viral epitopes to redirect EBV-specific CD8
    van der Wulp W; Remst DFG; Kester MGD; Hagedoorn RS; Parren PWHI; van Kasteren SI; Schuurman J; Hoeben RC; Ressing ME; Bleijlevens B; Heemskerk MHM
    Cancer Gene Ther; 2024 Jan; 31(1):58-68. PubMed ID: 37945970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of methods generating antibody-epitope conjugates for targeting cancer with virus-specific T cells.
    van der Wulp W; Gram AM; Bleijlevens B; Hagedoorn RS; Araman C; Kim RQ; Drijfhout JW; Parren PWHI; Hibbert RG; Hoeben RC; van Kasteren SI; Schuurman J; Ressing ME; Heemskerk MHM
    Front Immunol; 2023; 14():1183914. PubMed ID: 37261346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitization of Tumors for Attack by Virus-Specific CD8+ T-Cells Through Antibody-Mediated Delivery of Immunogenic T-Cell Epitopes.
    Sefrin JP; Hillringhaus L; Mundigl O; Mann K; Ziegler-Landesberger D; Seul H; Tabares G; Knoblauch D; Leinenbach A; Friligou I; Dziadek S; Offringa R; Lifke V; Lifke A
    Front Immunol; 2019; 10():1962. PubMed ID: 31555260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-mediated delivery of a viral MHC-I epitope into the cytosol of target tumor cells repurposes virus-specific CD8
    Jung K; Son MJ; Lee SY; Kim JA; Ko DH; Yoo S; Kim CH; Kim YS
    Mol Cancer; 2022 Apr; 21(1):102. PubMed ID: 35459256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-mediated delivery of viral epitopes to tumors harnesses CMV-specific T cells for cancer therapy.
    Millar DG; Ramjiawan RR; Kawaguchi K; Gupta N; Chen J; Zhang S; Nojiri T; Ho WW; Aoki S; Jung K; Chen I; Shi F; Heather JM; Shigeta K; Morton LT; Sepulveda S; Wan L; Joseph R; Minogue E; Khatri A; Bardia A; Ellisen LW; Corcoran RB; Hata AN; Pai SI; Jain RK; Fukumura D; Duda DG; Cobbold M
    Nat Biotechnol; 2020 Apr; 38(4):420-425. PubMed ID: 32042168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
    Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
    Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-Peptide Epitope Conjugates for Personalized Cancer Therapy.
    Zhang S; Yan C; Millar DG; Yang Q; Heather JM; Langenbucher A; Morton LT; Sepulveda S; Alpert E; Whelton LR; Zarrella DT; Guo M; Minogue E; Lawrence MS; Rueda BR; Spriggs DR; Lu W; Langenau DM; Cobbold M
    Cancer Res; 2022 Mar; 82(5):773-784. PubMed ID: 34965933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-mediated delivery of T-cell epitopes to antigen-presenting cells induce strong CD4 and CD8 T-cell responses.
    Høydahl LS; Frigstad T; Rasmussen IB; Øynebråten I; Schjetne KW; Andersen JT; Michaelsen TE; Lunde E; Bogen B; Sandlie I
    Vaccine; 2021 Mar; 39(11):1583-1592. PubMed ID: 33612340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity.
    Schödel F; Moriarty AM; Peterson DL; Zheng JA; Hughes JL; Will H; Leturcq DJ; McGee JS; Milich DR
    J Virol; 1992 Jan; 66(1):106-14. PubMed ID: 1370083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Novel T-Cell Epitopes on Infectious Bronchitis Virus N Protein and Development of a Multi-epitope Vaccine.
    Qin Y; Tu K; Teng Q; Feng D; Zhao Y; Zhang G
    J Virol; 2021 Aug; 95(17):e0066721. PubMed ID: 34105997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA/Ad5 vaccination with SIV epitopes induced epitope-specific CD4⁺ T cells, but few subdominant epitope-specific CD8⁺ T cells.
    Vojnov L; Bean AT; Peterson EJ; Chiuchiolo MJ; Sacha JB; Denes FS; Sandor M; Fuller DH; Fuller JT; Parks CL; McDermott AB; Wilson NA; Watkins DI
    Vaccine; 2011 Oct; 29(43):7483-90. PubMed ID: 21839132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sortase-mediated modification of αDEC205 affords optimization of antigen presentation and immunization against a set of viral epitopes.
    Swee LK; Guimaraes CP; Sehrawat S; Spooner E; Barrasa MI; Ploegh HL
    Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1428-33. PubMed ID: 23297227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in the study of HLA-restricted epitope vaccines.
    Zhao L; Zhang M; Cong H
    Hum Vaccin Immunother; 2013 Dec; 9(12):2566-77. PubMed ID: 23955319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico analysis of MHC-I restricted epitopes of Chikungunya virus proteins: Implication in understanding anti-CHIKV CD8(+) T cell response and advancement of epitope based immunotherapy for CHIKV infection.
    Pratheek BM; Suryawanshi AR; Chattopadhyay S; Chattopadhyay S
    Infect Genet Evol; 2015 Apr; 31():118-26. PubMed ID: 25643869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Both CD4+ and CD8+ T cell epitopes fused to heat shock cognate protein 70 (hsc70) can function to eradicate tumors.
    Mizukami S; Kajiwara C; Ishikawa H; Katayama I; Yui K; Udono H
    Cancer Sci; 2008 May; 99(5):1008-15. PubMed ID: 18341654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of CD8(+) T-lymphocyte responses to multiple epitopes from simian virus 40 (SV40) large T antigen in C57BL/6 mice immunized with SV40, SV40 T-antigen-transformed cells, or vaccinia virus recombinants expressing full-length T antigen or epitope minigenes.
    Mylin LM; Schell TD; Roberts D; Epler M; Boesteanu A; Collins EJ; Frelinger JA; Joyce S; Tevethia SS
    J Virol; 2000 Aug; 74(15):6922-34. PubMed ID: 10888631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a novel ZIKV vaccine comprised of immunodominant CD4+ and CD8+ T cell epitopes identified through comprehensive epitope mapping in Zika virus infected mice.
    Sun J; Zheng Z; Li M; Liu Z; Su X; Jin X
    Vaccine; 2021 Aug; 39(36):5173-5186. PubMed ID: 34353682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human CLEC9A antibodies deliver NY-ESO-1 antigen to CD141
    Masterman KA; Haigh OL; Tullett KM; Leal-Rojas IM; Walpole C; Pearson FE; Cebon J; Schmidt C; O'Brien L; Rosendahl N; Daraj G; Caminschi I; Gschweng EH; Hollis RP; Kohn DB; Lahoud MH; Radford KJ
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32737142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inefficient cross-presentation limits the CD8+ T cell response to a subdominant tumor antigen epitope.
    Otahal P; Hutchinson SC; Mylin LM; Tevethia MJ; Tevethia SS; Schell TD
    J Immunol; 2005 Jul; 175(2):700-12. PubMed ID: 16002665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.